Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
History
Health & Fitness
Technology
About Us
Contact Us
Copyright
© 2024 PodJoint
Loading...
0:00 / 0:00
Podjoint Logo
US
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts122/v4/d8/5d/96/d85d96c8-1597-181d-ee91-2f445a3af2eb/mza_3017484506386797643.jpg/600x600bb.jpg
Targeting the Toughest Diseases
Vertex Pharmaceuticals
7 episodes
4 months ago
Targeting the Toughest Diseases looks at some of humanity’s most challenging diseases and how Vertex Pharmaceuticals, a Boston-based biotech company, is using innovative tools, methods, and a unique philosophy to search for treatments and cures. Produced by Bloomberg Media Studios and Vertex Pharmaceuticals.
Show more...
Natural Sciences
Technology,
Science,
Life Sciences
RSS
All content for Targeting the Toughest Diseases is the property of Vertex Pharmaceuticals and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Targeting the Toughest Diseases looks at some of humanity’s most challenging diseases and how Vertex Pharmaceuticals, a Boston-based biotech company, is using innovative tools, methods, and a unique philosophy to search for treatments and cures. Produced by Bloomberg Media Studios and Vertex Pharmaceuticals.
Show more...
Natural Sciences
Technology,
Science,
Life Sciences
Episodes (7/7)
Targeting the Toughest Diseases
Targeting Duchenne Muscular Dystrophy
John Killian’s son was diagnosed with Duchenne muscular dystrophy (DMD) as a toddler. Until recently, children with DMD were not expected to live beyond their teens. The disease weakens the body's muscles and cognitive functions, which can lead to premature death. John’s son is now college-bound, thanks to the help of medical advancements that target the symptoms of the disease. Geneticist Dr. Alison McVie-Wylie and the research team at Vertex hope to move past only treating the symptoms of DMD by addressing the disease at its root cause. Produced by Bloomberg Media Studios and Vertex Pharmaceuticals.
Show more...
2 years ago
14 minutes 7 seconds

Targeting the Toughest Diseases
Targeting Pain
Damian Sanchez, (Damian J to music fans) is a Miami-based jazz musician. A car accident landed him in the hospital with multiple fractures to his leg. Once there, he faced the difficult decision of whether or not to take the pain medication that was offered to him. With patients like Damian in mind, Dr. Paul Negulescu and the research team at Vertex are thinking differently about pain – they’re investigating potential non-opioid based treatment options that aim to target pain differently. Produced by Bloomberg Media Studios and Vertex Pharmaceuticals.
Show more...
2 years ago
12 minutes 45 seconds

Targeting the Toughest Diseases
Targeting Type 1 Diabetes
Madison Carter is a fearless investigative reporter. She takes no day for granted because she lives with type 1 diabetes (T1D). Dr. Doug Melton is a world-renowned stem cell researcher and distinguished fellow at Vertex – and his now grown children, Sam and Emma, live with T1D. Along with scientists like Dr. Felicia Pagliuca, who leads Vertex’s research into T1D, he’s been on a quest to help Madison, Sam, Emma, and others like them by investigating the disease at a cellular level. Produced by Bloomberg Media Studios and Vertex Pharmaceuticals.
Show more...
2 years ago
16 minutes 33 seconds

Targeting the Toughest Diseases
Targeting Genetic Kidney Disease
NBA great Alonzo Mourning returned home from the Sydney Olympics after winning the gold medal feeling ill. He surprisingly was diagnosed shortly after with kidney disease. Scientists have discovered his type of kidney disease is linked to having genetic variants of the APOL1 gene – ones that 13% of African Americans carry. Dr. Ogo Egbuna leads clinical development for the team researching APOL1-mediated kidney disease at Vertex where they’re investigating a potential therapy to target its underlying cause. Alonzo Mourning is a paid spokesperson for Vertex Pharmaceuticals. Produced by Bloomberg Media Studios and Vertex Pharmaceuticals.
Show more...
2 years ago
16 minutes 54 seconds

Targeting the Toughest Diseases
Targeting Sickle Cell Disease
Terri Booker’s body burns with pain. She’s one of the 100,000 Americans living with sickle cell disease – a blood disorder that can cause severe pain, organ failure, and even premature death. The genetic condition came about to protect against malaria. Dr. William Hobbs leads clinical development for sickle cell disease at Vertex, and they are investigating multiple approaches to address the unmet needs that patients face. Produced by Bloomberg Media Studios and Vertex Pharmaceuticals.
Show more...
2 years ago
15 minutes 48 seconds

Targeting the Toughest Diseases
Targeting Cystic Fibrosis
NFL quarterback Boomer Esiason’s career high came just days before his son was diagnosed with cystic fibrosis (CF) – a genetic disease characterized by thick and sticky mucus that interferes with breathing, digestion and the body’s ability to fight infections. Esiason now dedicates his free time to raising awareness to fund the search for a cure. We explore how Vertex’s Chief Scientific Officer, Dr. David Altshuler, and the research team at Vertex have spent the last 20+ years researching the underlying cause of the disease – and their work is not yet finished. Produced by Bloomberg Media Studios and Vertex Pharmaceuticals.
Show more...
2 years ago
14 minutes 8 seconds

Targeting the Toughest Diseases
Introducing, Targeting the Toughest Diseases
Targeting the Toughest Diseases looks at some of humanity’s most challenging diseases and how Vertex, a Boston-based biotech company, is using innovative tools, methods, and a unique philosophy to search for treatments and cures. Produced by Bloomberg Media Studios and Vertex Pharmaceuticals. The first episode drops October 10th. Subscribe today.
Show more...
2 years ago
3 minutes

Targeting the Toughest Diseases
Targeting the Toughest Diseases looks at some of humanity’s most challenging diseases and how Vertex Pharmaceuticals, a Boston-based biotech company, is using innovative tools, methods, and a unique philosophy to search for treatments and cures. Produced by Bloomberg Media Studios and Vertex Pharmaceuticals.